Rapid, high throughput determination of cervical cytology specimen adequacy using a capillary-based cytometer

Cytometry Part B - Clinical Cytometry

Volumn 74, Issue 2, 2008, Pages 133-136

  Polina, Ryan ^a   Sturgis, Charles ^b   Patterson, John ^a   Patterson, Bruce K ^c  

^a Invirion Diagnostics LLC   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bethesda system; Cervical cytology; Liquid based cytology; Specimen adequacy; ThinPrep; Unsatisfactory

Indexed keywords

ARTICLE; CAPILLARY BED CYTOMETRY; CELL COUNT; CYTOMETER; CYTOPATHOLOGY; FEMALE; FLOW CYTOMETRY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LIQUID; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CYTOLOGY;

CARCINOMA; CELL COUNT; CERVIX UTERI; CYTOLOGICAL TECHNIQUES; FEMALE; FLOW CYTOMETRY; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; TIME FACTORS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 42549088546     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20385     Document Type: Article

References (19)

1. American Cancer Society. 2006.
2. Kurman RJ, Soloman D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnosis, 1st edition. New York: Springer-Verlag; 1994.
3. Clinical laboratory improvement amendments of 1988. Fed Regist 1992;57:7169.
4. URL: http://bethesda2001.cancer.gov.
5. Wilbur DC, Facik MS, Rutkowski MA, Mulford DK, Atkison KM. Clinical trials of the CYTORICH specimen-preparation device for cervical cytology. Acta Cytol 1997;41:24-29.
6. Corkill M, Knapp D, Martin J, Hutchinson ML. Specimen adequacy of the ThinPrep sample preparations in a direct-to-vial study. Acta Cytol 1997;41:39-44.
7. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-819.
8. Grundhoefer D, Patterson BK. Determination of liquid-based cervical cytology specimen adequacy using cellular light scatter and flow cytometry. Cytometry 2001;46:340-344.
9. Davey DD, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: Current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Path Lab Med 2000;124:203-211.
10. Islam S, West AM, Saboorian MH, Ashfaq R. Reprocessing unsatisfactory ThinPrep Papanicolaou test specimens increases sample adequacy and detection of significant cervicovaginal lesions. Cancer 2004;102:67-73.
11. Birdsong GG. Pap smear adequacy: Is our understanding satisfactory... or limited? Diagn Cytopathol 2001;24:79-81.
12. Henry JA, Wadehra V. Influence of smear quality on the rate of detecting significant cervical cytologic abnormalities. Acta Cytol 1996;40:529-535.
13. Mintzer MP, Curtis, Resnick JC, Morrell D. The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities. Cancer Cytopathol 1999;87:113-117.
14. Renshaw AA, Friedman MM, Rahemtulla A, Granter SR, Dean BR, Cronin JA, Jiroutek M, Cibas ES. Accuracy and reproducibility of estimating the adequacy of the squamous component of cervicovaginal smears. Am J Clin Pathol 1999;111:38-42.
15. Valente PT, Schantz HD, Trabal JF. The determination of Papanicolaou smear adequacy using a semiquantitative method to evaluate cellularity. Diagn Cytopathol 1991;7:576-580.
16. Crothers BA. The Bethesda System 2001: Update on terminology and application. Clin Obstet Gynecol 2005;48:98-107.
17. Gill GW. Pap smear cellular adequacy: What does 10% coverage look like?: What does it mean? Acta Cytol 2000;44:873.
18. Narimatsu R, Patterson BK. High throughput cervical cancer screening using intracellular HPV E6, E7 mRNA quantification by flow cytometry. Am J Clin Pathol 2005;123:716-723.
19. Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei G, Carozzi, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J. Human papillomavirus testing and liquid-based cytology: Results at recruitment from the new technologies for Cervical Cancer Randomized Controlled Trial. J Natl Cancer Inst 2006;98:765-774.